• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草药治疗特发性矮小儿童的成本效果分析。

Cost-effectiveness analysis of herbal medicines in children with idiopathic short stature.

机构信息

Department of Preventive Medicine, College of Korean Medicine, Daegu Haany University, Gyeongsangbuk-do, Republic of Korea.

Department of Korean Pediatrics, College of Korean Medicine Kyung Hee University, Kyung Hee University Medical Center, Seoul, Republic of Korea.

出版信息

Medicine (Baltimore). 2023 Mar 10;102(10):e33193. doi: 10.1097/MD.0000000000033193.

DOI:10.1097/MD.0000000000033193
PMID:36897666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9997761/
Abstract

BACKGROUND

Herbal medicines have been used for a long time to treat idiopathic short stature (ISS) in children in East Asian countries. The aim of this study was to analyze the cost-effectiveness of 5 herbal medicines frequently used in clinical settings for children with ISS based on medical records.

METHODS

Patients with ISS who had been prescribed a 60-day supply of herbal medicines in 1 Korean medicine hospital were included in this analysis. Their height and height percentile were measured before and after treatment within 6-months. The average cost-effectiveness ratios (ACERs) of 5 herbal medicines for height (cm) and height percentile were calculated for boys and girls, respectively.

RESULTS

The ACERs per 1 cm height growth were USD 56.2 (Naesohwajung-Tang), USD 74.8 (Ogapi-Growth decoction), USD 86.6 (Gamcho-Growth decoction), USD 94.6 (Gwakhyangjeonggi-San plus Yukmijihwang-Tang), and USD 113.8 (Boyang-Growth decoction). The ACERs per 1 percentile height growth were USD 205 (Naesohwajung-Tang), USD 293 (Ogapi-Growth decoction), USD 470 (Gamcho-Growth decoction), USD 949 (Boyang-Growth decoction), and USD 1051 (Gwakhyangjeonggi-San plus Yukmijihwang-Tang).

CONCLUSION

Herbal medicine might be a potential economical alternative treatment for ISS.

摘要

背景

在东亚国家,草药已被长期用于治疗儿童特发性身材矮小症(ISS)。本研究旨在根据病历分析 5 种常用于临床治疗 ISS 儿童的草药的成本效益。

方法

本分析纳入了在 1 家韩医院接受 60 天草药治疗的 ISS 患者。在 6 个月内,他们在治疗前后的身高和身高百分位均进行了测量。分别计算了 5 种草药对男孩和女孩身高(cm)和身高百分位的平均成本效益比(ACER)。

结果

身高每增长 1cm 的 ACER 分别为 56.2 美元(奶儿汤)、74.8 美元(大长今汤)、86.6 美元(甘草成长汤)、94.6 美元(加味八珍汤加六味地黄汤)和 113.8 美元(男孩成长汤)。身高百分位每增长 1%的 ACER 分别为 205 美元(奶儿汤)、293 美元(大长今汤)、470 美元(甘草成长汤)、949 美元(加味八珍汤加六味地黄汤)和 1051 美元(加味八珍汤加六味地黄汤)。

结论

草药可能是 ISS 的一种有潜力的经济替代治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e31/9997761/99dd7832f7bf/medi-102-e33193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e31/9997761/99dd7832f7bf/medi-102-e33193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e31/9997761/99dd7832f7bf/medi-102-e33193-g001.jpg

相似文献

1
Cost-effectiveness analysis of herbal medicines in children with idiopathic short stature.草药治疗特发性矮小儿童的成本效果分析。
Medicine (Baltimore). 2023 Mar 10;102(10):e33193. doi: 10.1097/MD.0000000000033193.
2
The effect of growth hormone treatment on height in children with idiopathic short stature.生长激素治疗对特发性身材矮小儿童身高的影响。
J Pediatr Endocrinol Metab. 2014 Jul;27(7-8):629-33. doi: 10.1515/jpem-2013-0461.
3
Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.生长激素治疗特发性身材矮小儿童的身高增长和安全性结果:来自前瞻性观察研究的经验。
Horm Res Paediatr. 2019;91(4):241-251. doi: 10.1159/000500087. Epub 2019 Jun 11.
4
Integrative traditional Korean medicine treatment for children with idiopathic short stature: A STROBE-compliant case series.整合传统韩医学疗法治疗特发性身材矮小儿童:一项符合 STROBE 原则的病例系列研究。
Medicine (Baltimore). 2022 Jul 15;101(28):e29754. doi: 10.1097/MD.0000000000029754.
5
Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.澳大利亚的生长激素治疗方案:特发性生长激素缺乏症和特发性身材矮小症治疗的头 3 年分析。
Clin Endocrinol (Oxf). 2012 Jul;77(1):62-71. doi: 10.1111/j.1365-2265.2011.04230.x.
6
Factors affecting bone age maturation during 3 years of growth hormone treatment in patients with idiopathic growth hormone deficiency and idiopathic short stature: Analysis of data from the LG growth study.特发性生长激素缺乏症和特发性身材矮小患者在生长激素治疗3年期间影响骨龄成熟的因素:来自LG生长研究的数据分析
Medicine (Baltimore). 2019 Apr;98(14):e14962. doi: 10.1097/MD.0000000000014962.
7
Combined therapy with GnRH analogue and growth hormone increases adult height in children with short stature and normal pubertal onset.促性腺激素释放激素类似物与生长激素联合治疗可增加青春期正常启动的矮小儿童的成人身高。
Endocrine. 2020 Sep;69(3):615-624. doi: 10.1007/s12020-020-02375-5. Epub 2020 Jun 12.
8
Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial.韩国特发性身材矮小青春期前儿童的重组人生长激素治疗:一项 III 期随机试验。
J Endocrinol Invest. 2018 Apr;41(4):475-483. doi: 10.1007/s40618-017-0786-8. Epub 2017 Nov 4.
9
Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.生长激素对无生长激素缺乏的矮小儿童最终身高的剂量依赖性效应
J Clin Endocrinol Metab. 2008 Nov;93(11):4342-50. doi: 10.1210/jc.2008-0707. Epub 2008 Aug 26.
10
The effect of treatment with recombinant human growth hormone (rhGH) on linear growth and adult height in children with idiopathic short stature (ISS): a systematic review and meta-analysis.重组人生长激素(rhGH)治疗对特发性矮小(ISS)儿童线性生长及成人身高的影响:一项系统评价与荟萃分析
J Pediatr Endocrinol Metab. 2020 Oct 9;33(12):1577-1588. doi: 10.1515/jpem-2020-0287. Print 2020 Dec 16.

引用本文的文献

1
Key elements of Korean medicine treatment for idiopathic short-stature: A qualitative SWOT analysis based on Korean medicine doctors' views.韩国医学治疗特发性身材矮小的关键要素:基于韩国医生观点的定性 SWOT 分析。
Medicine (Baltimore). 2024 Jul 26;103(30):e39116. doi: 10.1097/MD.0000000000039116.
2
Hand skeletal features of children and adolescents with different growth statuses and periods.不同生长状态和时期的儿童及青少年的手部骨骼特征。
Quant Imaging Med Surg. 2024 Mar 15;14(3):2528-2538. doi: 10.21037/qims-23-26. Epub 2024 Mar 5.
3
The Effects of Natural Product-Derived Extracts for Longitudinal Bone Growth: An Overview of In Vivo Experiments.
天然产物提取物对纵向骨生长的影响:体内实验综述。
Int J Mol Sci. 2023 Nov 22;24(23):16608. doi: 10.3390/ijms242316608.